Impact of Atrial Fibrillation on Hospitalization Outcomes of Heart Failure in Patients ≥ 60 Years with Implantable Cardioverter Defibrillator

      The impact of atrial fibrillation (AF) on the hospitalization outcomes in patients ≥ 60 years of age with implantable cardioverter defibrillators (ICD) is not well studied. We queried the National Inpatient Sample database for all patients aged ≥ 60 who had a history of ICD placement, and were admitted with a primary diagnosis of heart failure (HF) during the years 2016-2017. Patients were stratified into 2 groups based on their history of AF. The primary outcome of the study was all-cause in-hospital mortality. Secondary outcomes included cardiogenic shock, myocardial infarction (MI), ventricular fibrillation (VF), stroke and acute kidney injury (AKI). The association between different age strata and outcomes was investigated. The hospitalization outcomes were modeled using logistic regression. A total of 178,045 patients were included, of whom 56.2% had AF. AF correlated with increased mortality (A-OR 1.22 (95% CI: 1.06-1.4), p=0.005), cardiogenic shock (A-OR 1.21 (95%CI: 1.08-1.36), p<0.001), AKI (A-OR 1.12 (95%CI: 1.06-1.17), p<0.001 and lower risk for MI (A-OR 0.79 (95% CI: 0.68-0.9), p<0.001. There was no correlation between AF and risk for VF or stroke. A significant correlation between AF and higher risk for mortality, cardiogenic shock and AKI was demonstrated in ages ≤ 75, ≤ 75, and ≤ 80 years, respectively. In contrast, a significant correlation between AF and lower risk for MI is only demonstrated at age > 70 years. We conclude that AF is an independent predictor for increased all-cause in-hospital mortality and cardiogenic shock. Such risk is influenced by age.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Eapen ZJ
        • Greiner MA
        • Fonarow GC
        • Yuan Z
        • Mills RM
        • Hernandez AF
        • Curtis LH.
        Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction.
        Am Heart J. 2014; 167: 369-375.e2
        • Staerk L
        • Sherer JA
        • Ko D
        • Benjamin EJ
        • Helm RH.
        Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes.
        Circ Res. 2017; 120: 1501-1517
        • Galderisi M
        • Santoro C
        • Esposito R.
        Left atrial function and dyssynchrony: Main characters and not actor appearances in heart failure with preserved ejection fraction.
        Int J Cardiol. 2018; 257: 222-223
        • Zathar Z
        • Karunatilleke A
        • Fawzy AM
        • Lip GYH.
        Atrial Fibrillation in Older People: Concepts and Controversies.
        Front Med. 2019; 6 (Available at:)
        • Mustafa Usman
        • Dherange Parinita
        • Reddy Rohit
        • DeVillier Joseph
        • Chong Jessica
        • Ihsan Alarozia
        • Jones Ryan
        • Duddyala Narendra
        • Reddy Pratap
        • Dominic Paari
        Atrial fibrillation is associated with higher overall mortality in patients with implantable cardioverter-defibrillator: a systematic review and meta-analysis.
        J Am Heart Assoc. 2018; 7e010156
        • Baalman SWE
        • Boersma LVA
        • Allaart CP
        • Meine M
        • Scheerder COS
        • Groot JR de
        Silent atrial fibrillation in patients with an implantable cardioverter defibrillator and coronary artery disease (INDICO AF) trial: study rationale and design.
        Neth Heart J. 2018; 26: 628-633
      1. Anon. HCUP-US Overview. Available at: Accessed May 25, 2019.

        • Holcomb ZC.
        Interpreting Basic Statistics: A Guide and Workbook Based on Excerpts from Journal Articles.
        Taylor & Francis, 2016
        • Batul SA
        • Gopinathannair R.
        Atrial fibrillation in heart failure: a therapeutic challenge of our times.
        Korean Circ J. 2017; 47: 644-662
        • Benjamin EJ
        • Wolf PA
        • D'Agostino RB
        • Silbershatz H
        • Kannel WB
        • Levy D
        Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.
        Circulation. 1998; 98: 946-952
        • Mamas MA
        • Caldwell JC
        • Chacko S
        • Garratt CJ
        • Fath-Ordoubadi F
        • Neyses L.
        A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure.
        Eur J Heart Fail. 2009; 11: 676-683
        • Cheng M
        • Lu X
        • Huang J
        • Zhang J
        • Zhang S
        • Gu D.
        The prognostic significance of atrial fibrillation in heart failure with a preserved and reduced left ventricular function: insights from a meta-analysis.
        Eur J Heart Fail. 2014; 16: 1317-1322
        • Chen LY
        • Benditt DG
        • Alonso A.
        Atrial fibrillation and its association with sudden cardiac death.
        Circ J Off J Jpn Circ Soc. 2014; 78: 2588-2593
        • Eisen A
        • Ruff CT
        • Braunwald E
        • Nordio F
        • Corbalán R
        • Dalby A
        • Dorobantu M
        • Mercuri M
        • Lanz H
        • Rutman H
        • Wiviott SD
        • Antman EM
        • Giugliano RP.
        Sudden cardiac death in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial.
        J Am Heart Assoc. 2016; 5e003735
        • Mazek H
        • Omar S
        • Prabhakar S.
        Prognostic implications of atrial fibrillation on patients admitted with acute decopensated heart failure and acute kidney injury.
        J Card Fail. 2019; 25: S58
        • Chan L
        • Mehta S
        • Chauhan K
        • Poojary P
        • Patel S
        • Pawar S
        • Patel A
        • Correa A
        • Patel S
        • Garimella PS
        • Annapureddy N
        • Agarwal SK
        • Gidwani U
        • Coca SG
        • Nadkarni GN.
        National trends and impact of acute kidney injury requiring hemodialysis in hospitalizations with atrial fibrillation.
        J Am Heart Assoc. 2016; 5
      2. Anon. Acute kidney injury in heart failure: a population study. Available at: Accessed January 14, 2021.

        • Lee HY
        • Yang P-S
        • Kim T-H
        • Uhm J-S
        • Pak H-N
        • Lee M-H
        • Joung B.
        Atrial fibrillation and the risk of myocardial infarction: a nation-wide propensity-matched study.
        Sci Rep. 2017; 7: 12716
        • Wändell P
        • Carlsson AC
        • Holzmann MJ
        • Ärnlöv J
        • Johansson S-E
        • Sundquist J
        • Sundquist K.
        Warfarin treatment and risk of myocardial infarction – a cohort study of patients with atrial fibrillation treated in primary health care.
        Int J Cardiol. 2016; 221: 789-793
        • Lee CJ-Y
        • Gerds TA
        • Carlson N
        • Bonde AN
        • Gislason GH
        • Lamberts M
        • Olesen JB
        • Pallisgaard JL
        • Hansen ML
        • Torp-Pedersen C.
        Risk of myocardial infarction in anticoagulated patients with atrial fibrillation.
        J Am Coll Cardiol. 2018; 72: 17-26
        • Smith P
        • Arnesen H
        • Holme I.
        The effect of warfarin on mortality and reinfarction after myocardial infarction.
        N Engl J Med. 1990; 323: 147-152